Free shipping on all orders over $ 500
Inhibitors
| Cat.No. | Name | Information |
|---|---|---|
| M7325 | Rimonabant Hydrochloride | Rimonabant hydrochloride is a cannabinoid receptor antagonist, which binds selectively to central cannabinoid receptors (CB1) with high affinity |
| M14560 | Pregnenolone monosulfate | Pregnenolone monosulfate (3β-Hydroxy-5-pregnen-20-one monosulfate) is a powerful neurosteroid, the main precursor of various steroid hormones including steroid ketones. |
| M13918 | Synaptamide | Synaptamide (Dehydroepiandrosteron; DHEA) is an endogenous metabolite and structural analogue of Anandamide. |
| M13917 | Anandamide | Anandamide is an immune modulator in the central nervous system acts via not only cannabinoid receptors (CB1 and CB2) but also other targets (e.g., GPR18/GPR55). |
| M10720 | A-836339 | A-836339 is a selective agonist of the cb2 receptor and has little effect on the cb1 receptor. |
| M10652 | Voacamine | Voacamine is an indole alkaloid, exhibits potent cannabinoid CB1 receptor antagonistic activity. Voacamine also inhibits P-glycoprotein (P-gp) action in multidrug-resistant tumor cells. |
| M10218 | (+)-Gallocatechin | (+)-Gallocatechin is found notably in green tea, it has moderate affinity to the human cannabinoid receptor and acts as an antioxidant. |
| M9691 | JD-5037 | JD-5037 is a cannabinoid-1 receptor blocker (CB1R antagonist) with IC50 of 1.5 nM. |
| M9652 | CB1-IN-1 | CB1-IN-1 is a novel potent restricted CB1R antagonist with Ki of 0.3 nM and 21 nM for CB1R and CB2R, respectively. |
| M9136 | Cannabidiol | Cannabidiol is a GPR55 and weak CB1 antagonist with IC50s of 0.445 and 3.35 μM, it is also a CB2 receptor inverse agonist and inhibitor of anandamide uptake with IC50 of 27.5 μM. |
| M8985 | LY2828360 | LY2828360 is a novel potent, selective, and efficacious CB2 cannabinoid agonist. |
| M8919 | BAY 59-3074 | BAY-59-3074 is a novel cannabinoid CB1/CB2 receptor partial agonist with Ki values of 48.3 and 45.5 nM at human CB1 and CB2 receptors, respectively. |
| M7325 | Rimonabant Hydrochloride | Rimonabant hydrochloride is a cannabinoid receptor antagonist, which binds selectively to central cannabinoid receptors (CB1) with high affinity |
| M7071 | O-2050 | O-2050 is a putative CB1 silent antagonist; displays mixed activity at CB receptors. |
| M6429 | AM 630 | AM 630 is a CB2 selective inverse agonist. |
| M5290 | (±)-SLV-319 | (±)-SLV319 (Ibipinabant) is a potent and selective CB1 receptor antagonist (Ki = 7.8 nM). Exhibits 1000-fold selectivity for CB1 over CB2 receptors. Inhibits CP 55,940-induced hypotension and WIN 55,212-2-induced hypothermia in vivo. |
| M3282 | GW842166X | GW842166X is a potent and highly selective agonist of cannabinoid receptor CB2 receptor with EC50 of 63 nM, shows no significant activity at CB1 receptor. |
| M3266 | WIN 55212-2 mesylate | WIN 55212-2 is a potent nanomolar affinity cannabinoid receptor agonist with Ki of 62.3 and 3.3 nM at the human cloned CB1 and CB2 receptors respectively. |
| M2981 | Rimonabant | Rimonabant is a selective antagonist of CB1 with IC50 of 13.6 nM and EC50 of 17.3 nM in hCB1 transfected HEK 293 membrane. |
| M2552 | CP 945598 | CP 945598 (Otenabant) is a selective, high affinity, competitive CB1 receptor antagonist with Ki of 0.7 nM. |
| M2461 | BML-190 | BML-190 is a selective cannabinoid CB2 receptor inverse agonist with Ki of 435 nM, with 50-fold selectivity over CB1 receptor. |
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2020 AbMole BioScience. All Rights Reserved.
